Technical Analysis for EMMA - Emmaus Life Sciences Inc

Grade Last Price % Change Price Change
grade D 1.51 -8.48% -0.1400
EMMA closed down 8.48 percent on Wednesday, February 26, 2020, on 51 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical EMMA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Stochastic Sell Signal Bearish -8.48%
180 Bearish Setup Bearish Swing Setup -8.48%
Narrow Range Bar Range Contraction -8.48%
Inside Day Range Contraction -8.48%
Wide Bands Range Expansion -8.48%
Older signals for EMMA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Emmaus Life Sciences, Inc. engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases in the United States and internationally. It provides Endari, which is L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older; NutreStore L-glutamine powder; and AminoPure, a nutritional supplement. The company also develops therapeutic products based on cell sheet technology for the treatment of corneal diseases. In addition, it focuses on developing pharmaceutical-grade L-glutamine oral powder for diverticulosis. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.
Medicine Health Medical Specialties Pharmaceutical Medication Therapeutic Products Sickle Cell Disease Rare And Orphan Diseases Therapeutic Cell Sheet Technology Corneal Diseases Diverticulosis Endari Glutamine Treatment Of Corneal Diseases

Is EMMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.85
52 Week Low 0.95
Average Volume 27,456
200-Day Moving Average 0.0000
50-Day Moving Average 1.7675
20-Day Moving Average 1.5660
10-Day Moving Average 1.7610
Average True Range 0.2060
ADX 13.46
+DI 19.9514
-DI 25.2792
Chandelier Exit (Long, 3 ATRs ) 1.3170
Chandelier Exit (Short, 3 ATRs ) 1.5680
Upper Bollinger Band 2.1306
Lower Bollinger Band 1.0014
Percent B (%b) 0.45
BandWidth 72.1073
MACD Line 0.0087
MACD Signal Line -0.0050
MACD Histogram 0.0137
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.7350
Resistance 3 (R3) 1.7600 1.7100 1.6975
Resistance 2 (R2) 1.7100 1.6527 1.6975 1.6850
Resistance 1 (R1) 1.6100 1.6173 1.5850 1.5850 1.6725
Pivot Point 1.5600 1.5600 1.5475 1.5475 1.5600
Support 1 (S1) 1.4600 1.5027 1.4350 1.4350 1.3475
Support 2 (S2) 1.4100 1.4673 1.3975 1.3350
Support 3 (S3) 1.3100 1.4100 1.3225
Support 4 (S4) 1.2850